At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share.
Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.
Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem’s proven team of experienced process and engineering teams has the knowledge to help our clients get things done.
Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.
-
所属行业
-
制药业
-
规模
-
5,001-10,000 人
-
总部
-
TEDA，Tianjin
-
类型
-
上市公司
-
创立
-
1999
-
领域
-
Process R&D、Continuous Flow chemistry、Biocatalysis、Hydrogenation、CMC、API、Small Molecule、Validation、HPAPI、Commercial Manufacturing、CDMO、USFDA inspected、Development、Late Clinical Phase、CMO、cGMP、ICH Q7A、R&D、Kilo Scale和Pilot Plant
